Main Street Research’s PDL BioPharma, Inc. PDLI Stock Holding History

Main Street Research’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-373,131	Closed	–	–	153
2021 Q2	$0	Buy	+373,131	New	–	﹤0.01%	152

Other funds holding PDLI

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Public Employees Retirement Association of Colorado Denver, Colorado $25.5B AUM 28.85% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Main Street Research's PDLI Position: Q3 2021 in Review

Main Street Research sold out of PDL BioPharma, Inc. (PDLI) in Q3 2021, closing a stake of 373,131 shares.

Main Street Research first reported a position in PDLI in Q2 2021 and held it in 1 quarter. The position peaked at $0 in Q2 2021. 8 funds tracked by Wall St. Rank hold PDLI as of Q3 2021.

Main Street Research reported no remaining PDL BioPharma, Inc. position as of Q3 2021 after selling out during the quarter.
Main Street Research sold 373,131 PDL BioPharma, Inc. shares in Q3 2021.
Main Street Research first reported a position in PDL BioPharma, Inc. in Q2 2021 and held it in 1 quarter.
Main Street Research's PDL BioPharma, Inc. position peaked at $0 in Q2 2021.
8 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q3 2021.

Based on Main Street Research's 13F filing for Q3 2021, filed 12 Nov 2021.